Search Results
You are looking at 1 - 1 of 1 items for
- Author: A D Nash x
- Refine by access: All content x
Search for other papers by D J Phillips in
Google Scholar
PubMed
Search for other papers by M P Hedger in
Google Scholar
PubMed
Search for other papers by J R McFarlane in
Google Scholar
PubMed
Search for other papers by R Klein in
Google Scholar
PubMed
Search for other papers by I J Clarke in
Google Scholar
PubMed
Search for other papers by A J Tilbrook in
Google Scholar
PubMed
Search for other papers by A D Nash in
Google Scholar
PubMed
Search for other papers by D M de Kretser in
Google Scholar
PubMed
Abstract
Plasma follistatin (FS) concentrations were determined after castration (n=5) or sham castration (n=4) of mature rams. Both treatments resulted in a prolonged increase in FS between 7 and 19 h after surgery, which returned to pretreatment concentrations by 24 h. Tumour necrosis factor-α (TNF-α), a sensitive marker of an acute-phase response, was undetectable in plasma, indicating that the FS response was not induced by trauma due to surgery. In a second experiment, injection of castrated rams (n=4) with ovine recombinant interleukin-1β, an acute-phase mediator, resulted in a sustained rise in FS concentrations within 4 h of injection. Plasma TNF-α concentrations increased transiently within 1 h of interleukin-1β injection, indicating that an acute-phase response had been initiated. Plasma follicle-stimulating hormone (FSH) concentrations were significantly decreased at 8 and 24 h after interleukin-1β injection, strongly suggestive of an inhibitory effect of increased FS concentrations on the secretion of FSH. Injection of castrated rams (n=2) with a control preparation of recombinant interleukin-2 did not induce an acute-phase response, and plasma FS and FSH concentrations were unaffected. These data show that the testis is not a major source of circulating FS, that the increase in circulating FS following sham castration/castration is not due to an acute-phase response, but that conversely FS concentrations are modulated by the acute-phase mediator, interleukin-1β.
Journal of Endocrinology (1996) 151, 119–124
